Christopher Guttman-McCabe - 17 May 2022 Form 4 Insider Report for Anterix Inc. (ATEX)

Role: Chief Reg & Comm Officer
Signature: /s/ Gena Ashe, Attorney-in-Fact
Issuer symbol: ATEX
Transactions as of: 17 May 2022
Net transactions value: $0
Form type: 4
Filing time: 19 May 2022, 16:19:29 UTC
Previous filing: 17 Nov 2021
Next filing: 01 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ATEX	Common Stock	Award	$0	+12,655	+23%	$0.000000	68,576	17 May 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ATEX	Stock Option (Right to Buy)	Award	$0	+25,511		$0.000000	25,511	17 May 2022	Common Stock	25,511	$49.39	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the issuance of restricted stock units (the "RSUs"). 25% of the RSUs vest and become exercisable on May 17, 2023, with the remaining RSUs vesting in 3 equal annual installments thereafter.
F2	25% of the option shares vest and become exercisable on May 17, 2023, with the remaining option shares vesting in 3 equal annual installments thereafter.